BRCA1 and breast cancer: This study indicates that the response to NACT in BRCA1-driven BC is a categorical variable: some tumors are destined to completely disappear, with no signs of the residual disease even on the “molecular level”, while others cannot be eradicated by conventional therapeutic tools.